Wim A. Fleischmann

Statistics

Publications

Citations

212

H-Index

Active since

2019

Affiliations

Centre de Recherche Médicales de Lambaréné(Current)

Wim A. Fleischmann is an author at Centre de Recherche Médicales de Lambaréné specializing in infectious diseases, vaccine efficacy trials, and vaccination.

ORCID

Publications per year

2019–2024

Publications

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 175 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Virology +16

<i>In Vitro</i> Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli

Wim A. Fleischmann, Kerryl E. Greenwood‐Quaintance, Robin Patel · Antimicrobial Agents and Chemotherapy · 2019 · 25 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +13

Markers of prolonged hospitalisation in severe dengue

Mario Recker, Wim A. Fleischmann, Trinh Huu Nghia et al. · PLoS neglected tropical diseases · 2024 · 12 citations · Full text

Public Health, Health Sciences, Infectious Diseases +15

1–3 of 3